Rubin M - Search Results

1

Introduction for the Filler Special Issue.

Narins RS, Rubin M, Matarasso S. Narins RS, et al. Among authors: rubin m. Dermatol Surg. 2015 Dec;41 Suppl 1:S277. doi: 10.1097/DSS.0000000000000537. Dermatol Surg. 2015. PMID: 26618453 No abstract available.

2

A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds.

Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. Narins RS, et al. Among authors: rubin m. Dermatol Surg. 2003 Jun;29(6):588-95. doi: 10.1046/j.1524-4725.2003.29150.x. Dermatol Surg. 2003. PMID: 12786700 Clinical Trial.

3

Clinical conference: management of rare events following dermal fillers--focal necrosis and angry red bumps.

Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Narins RS, et al. Among authors: rubin m. Dermatol Surg. 2006 Mar;32(3):426-34. doi: 10.1111/j.1524-4725.2006.32086.x. Dermatol Surg. 2006. PMID: 16640693 No abstract available.

4

The science and art of dermal fillers for soft-tissue augmentation.

Carruthers J, Cohen SR, Joseph JH, Narins RS, Rubin M. Carruthers J, et al. Among authors: rubin m. J Drugs Dermatol. 2009 Apr;8(4):335-50. J Drugs Dermatol. 2009. PMID: 19363852 Review.

5

Correcting age-related changes in the face by use of injectable fillers and neurotoxins.

Rubin MG, Cox SE, Kaminer MS, Solish N. Rubin MG, et al. Semin Cutan Med Surg. 2014 Jun;33(4 Suppl):S81-4. doi: 10.12788/j.sder.0101. Semin Cutan Med Surg. 2014. PMID: 25268602

6

Review of the efficacy, durability, and safety data of two nonanimal stabilized hyaluronic acid fillers from a prospective, randomized, comparative, multicenter study.

Dover JS, Rubin MG, Bhatia AC. Dover JS, et al. Dermatol Surg. 2009 Feb;35 Suppl 1:322-30; discussion 330-1. doi: 10.1111/j.1524-4725.2008.01060.x. Dermatol Surg. 2009. PMID: 19207321 Clinical Trial.

7

An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.

Rubin M, Dover J, Maas C, Nestor M. Rubin M, et al. Aesthet Surg J. 2009 Nov;29(6 Suppl):S50-6. doi: 10.1016/j.asj.2009.09.010. Aesthet Surg J. 2009. PMID: 19945005

8

The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.

Rubin MG, Dover J, Glogau RG, Goldberg DJ, Goldman MP, Schlessinger J. Rubin MG, et al. J Drugs Dermatol. 2009 May;8(5):439-44. J Drugs Dermatol. 2009. PMID: 19537366 Clinical Trial.

9

Facial soft-tissue fillers conference: assessing the state of the science.

Rohrich RJ, Hanke CW, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R, Greenberger PE, Lorenc ZP, Marmur ES, Monheit GD, Pusic A, Rubin MG, Rzany B, Sclafani A, Taylor S, Weinkle S, McGuire MF, Pariser DM, Casas LA, Collishaw KJ, Dailey RA, Duffy SC, Edgar EJ, Greenan BL, Haenlein K, Henrichs RA, Hume KM, Lum F, Nielsen DR, Poulsen L, Shoaf L, Seward W, Begolka WS, Stanton RG, Svedman KJ, Thomas JR, Sykes JM, Wargo C, Weiss RA. Rohrich RJ, et al. Among authors: rubin mg. Plast Reconstr Surg. 2011 Apr;127(4 Suppl):22S-S. doi: 10.1097/PRS.0b013e31820578d0. Plast Reconstr Surg. 2011. PMID: 21490546

10

Novel post-treatment care after ablative and fractional CO2 laser resurfacing.

Duplechain JK, Rubin MG, Kim K. Duplechain JK, et al. J Cosmet Laser Ther. 2014 Apr;16(2):77-82. doi: 10.3109/14764172.2013.854625. Epub 2013 Nov 18. J Cosmet Laser Ther. 2014. PMID: 24131071 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,537 results

Search Page